Ignite Creation Date:
2025-12-24 @ 11:07 PM
Ignite Modification Date:
2025-12-30 @ 7:37 PM
Study NCT ID:
NCT01838369
Status:
TERMINATED
Last Update Posted:
2023-01-11
First Post:
2013-03-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of BI-505 in Smoldering Multiple Myeloma
Sponsor:
BioInvent International AB
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
12-BI-505-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None